Portside Wealth Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,163
Closed -$365K 544
2026
Q1
$365K Buy
6,163
+1,460
+31% +$94.7K 0.05% 330
2025
Q4
$290K Buy
4,703
+408
+9% +$25K 0.04% 372
2025
Q3
$268K Sell
4,295
-3,638
-46% -$253K 0.04% 404
2025
Q2
$633K Sell
7,933
-67
-0.8% -$5.6K 0.09% 208
2025
Q1
$688K Buy
8,000
+828
+12% +$67.9K 0.11% 194
2024
Q4
$560K Buy
7,172
+783
+12% +$60.8K 0.09% 213
2024
Q3
$461K Buy
6,389
+707
+12% +$50.1K 0.08% 238
2024
Q2
$391K Buy
5,682
+124
+2% +$8.4K 0.07% 240
2024
Q1
$403K Buy
5,558
+870
+19% +$58.2K 0.07% 238
2023
Q4
$287K Buy
+4,688
New +$278K 0.05% 273

Other funds holding PBH

Portside Wealth Group's PBH Position: Q2 2026 in Review

Portside Wealth Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 6,163 shares — an estimated $365K sold.

Portside Wealth Group first reported a position in PBH in Q4 2023 and held it in 10 quarters. The position peaked at $688K in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Portside Wealth Group reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Portside Wealth Group sold 6,163 Prestige Consumer Healthcare shares in Q2 2026, an estimated $365K.
  • Portside Wealth Group first reported a position in Prestige Consumer Healthcare in Q4 2023 and held it in 10 quarters.
  • Portside Wealth Group's Prestige Consumer Healthcare position peaked at $688K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.